Scientific interest in cannabinoids and sleep has increased significantly in recent years. A peer-reviewed study published in the Journal of Sleep Research examined the effects of a cannabinoid-based oil on adults experiencing insomnia-related sleep disturbances.
Key findings from the research
-
The study was designed as a randomised, double-blind, placebo-controlled crossover trial, considered a high standard in sleep research.
-
Participants using the active cannabinoid oil reported a significant improvement in overall sleep quality compared to placebo.
-
After the intervention period, approximately 60 percent of participants no longer met the criteria for clinical insomnia.
-
A notable increase in nighttime melatonin levels was observed in the active group, while melatonin decreased in the placebo group.
-
Improvements were seen in total sleep duration, particularly within lighter restorative sleep phases.
-
Enhanced sleep quality was associated with better daytime functioning, including reduced fatigue and improved mental clarity.
Relevance to CBD, CBDA and CBN
Although the study investigated a full cannabinoid formulation, the results align with broader research into CBD, CBDA and CBN. These cannabinoids are increasingly studied for their interaction with the endocannabinoid system, which plays a role in regulating sleep, stress response and recovery. Combining cannabinoids with melatonin and calming botanicals reflects a synergistic, nature-based approach to nighttime support.